This issue of the journal includes 2 communications relating to the possible genetic basis of 2 disorders of major health and socioeconomic relevance, intracranial aneurysms (IA) and abdominal aortic aneurysms (AAA). 1,2 One paper does not find a correlation between single nucleotide polymorphisms (SNPs) on chromosome 19q13 and sporadic AAA. The authors conclude that familial and sporadic aneurysms may have different origins. The other paper looks at the relationship between AAA and 2 loci, HSPG2 and CSPG2, which are thought to confer susceptibility to IA. In addition, in this work, no association is found between these loci and AAA.
In the case of aneurysms, factors in the vessel wall, not least the ECM with specific proteins like collagen and elastin and proteoglycans as well as the cells themselves, are obvious candidates in pathogenesis. The role of elastase (and other proteases), neutrophil influx and complement in the weakening of the wall of the aorta, has been investigated in a series of elegant rodent models, including the impact of chronic as opposed to short-term cigarette smoke exposure. [11] [12] [13] [14] A number of regions on chromosomes are increasingly implicated to contain sequences that appear to influence the development of arterial disease. These include chromosomes 9, 7, 5, and 19. 15, 16 Humphries' group identified 3 genes with possible relevance to AAA disease, the MTHFR gene (homocysteine metabolism), MMP9 gene (mediators of ECM protein degradation), and ACE gene (rennin-angiotensin system), and concluded that other candidate loci were not well supported. 16 This excellent review did not cover IA and unfortunately was written shortly before the publication of a report (to which the team of the 2 reports in this issue contributed) that a locus on chromosome 9p21 is linked to MI, AAA, and IA. 17 Following that report, there has been a plethora of studies on 9p21 in the cardiovascular area. Studies in healthy populations have found no explanatory effect of 9p21 on coronary artery disease (CAD) risk via blood pressure, cholesterol levels, body mass index (BMI), and smoking behavior (all established risk factors). 15 A Swedish collaborative group have described that genetic variation on chromosome 9p21.3 is associated with differences in arterial stiffness in men but not in women. 18 Briefly, the load-bearing functions in the arterial wall are exerted primarily by elastin and collagen working together. Elastin is loadbearing at low pressures and collagen is load-bearing at high pressures. In the physiological pressure range, only a minor part of the load bearing is provided by collagen. Abnormal functional characteristics of the abdominal aorta wall when subjected to pulsatile blood flow likely reflect changes in the integrity of the wall. Thus, aneurysm could be owed to a combination of changes in both protein systems. Nevertheless, these associations were seen only in men and not in women, which might have been due to a selection bias in the recruitment of female participants, though it could be that the aortic wall is more vulnerable in men than in women.
Inoue's group has reported that the collagen type I a2 gene (COL1A2) is a susceptibility gene for IA in Japanese. 19 This gene is located on chromosome 7q22.1. They found a point mutation that induces an Ala to Pro substitution at position 459, which is more rigid (has higher thermal stability). However, because the allelic frequency of this is low, the variant could account for only a portion of IA susceptibilities, and in their review, Humphries' team did not consider it well validated for AAA. 16 The same Japanese team has also investigated the loci for elastin (ELN) and a kinase (LIMK1) on chromosome 7q11. 20 The strongest association was in the ELN 3 0 -UTR, where there was a common tag for an insertion within the ELN 3 0 -UTR and LIMK1 promoter, which related to reduced transcript levels owed to accelerated ELN messenger RNA (mRNA) degradation and decreased LIMK1 promoter firing. They speculated that this combined effect might result in increased risk of IA through weakening of the vascular wall. Again, these loci were not supported in the AAA review by Thompson et al. 16 With the emergence of the importance of micro-RNAs (miRNA) in gene regulation, it is tempting to speculate that miRNA might be found to interact with or be present in these sequences (see also below). 21 Mutations in fibrillin, an essential part of the structure of elastin, lead to Marfan syndrome (defective in fibrillin-1) and these patients get thoracic aortic aneurysms. Recent data suggest that thoracic aneurysmal disease is part of a disrupted transforming growth factor bets (TGFb) pathway including that latent TGFb-binding protein (LTBP) may contribute to AAA progression. [22] [23] [24] It has been shown that fibrillin-1 and versican (one of the genes studied by Baas et al) can form a major hyaluronan-binding complex. 25 Although there has been considerable interest in homocysteine, Hcy in cardiovascular disease for more than 15 years, and the MTHFR gene was implicated in Humphries review, the large supplementation studies have not identified a benefit in terms of stroke, coronary events, or death, in spite of reducing the concentration in blood of homocysteine, Hcy and increasing those of folate and B 12 . 26 It should be noted that the majority of strokes are thrombotic (80%) and not hemorrhagic, and not usually owed to rupture of IA. [3] [4] [5] In addition, the mechanisms whereby homocysteine might cause endothelial damage and vascular disease are not well understood with a plethora of postulated links from direct toxicity to changes in DNA methylation patterns due to inhibition of transmethylation reactions. 27 It is not known exactly how sequence variants on 9p21 relate to other diseases. Various reports suggest that the locus may have a role in initiation but not progression of arterial disease, that is, an association with a CAD phenotype instead. [28] [29] [30] Thus, once a patient has developed CAD, the downstream events may not track with 9p21. This is probably not so surprising, given that acute arterial ischemic events tend to be related to thrombus formation on a ruptured atherosclerotic plaque. It has been reported that 9p21 is associated with the presence of AAA but does not have an impact on aneurysmal expansion in 2 geographically independent cohorts. 31 The AAA growth rate was assessed with a median surveillance period of 3.2 and 4.5 years. Using a different methodology, that of the whole transcriptome approach, the St George's Hospital vascular team compared gene expression at sites where AAA ruptured to expression at anterior sack biopsies. 32 They found 193 upregulated and 16 downregulated genes (using criteria of >2.5-fold and P < .005), the main ones being Il-6, IL-8, SELE, Cox2, PROK2. 32 Thus, an inflammatory component appears to be linked to rupture but cause or effect could not be determined. The same team previously described that AAA patients had significantly higher levels of circulating endothelial progenitor cells (EPCs) than age-matched controls and proposed angiogenesis-like events might be weakening the wall. 33 Furthermore, development of inflammatory AAA may be partly mediated by the proliferation of adventitial myofibroblasts, which might be related to tissue hypoxia. 34 In a study in 170 healthy donors looking at expression in peripheral blood T cells, a group at the University of North Carolina found significantly reduced expression of INK4/ARF transcripts (p15 INK4b , p16 INK4a , ARF, and ANRIL) in 1 chromosome 9p21 variant associated with increased MI, AAA, and stroke. 35 Expression of MTAP was not influenced. Nevertheless, they found no association with 5 other SNP variants in 9p21. ANRIL is particularly interesting because it is an untranslated sequence. mi-RNAs are short, untranslated, RNA sequences that play a role in gene regulation. 21 The original discoverers of ANRIL were not able to exclude that miRNA might be found in this sequence but this untranslated sequence is expressed in tissues and cell types affected by atherosclerosis and is a prime candidate gene. 36, 37 Given this involvement of genes of the cycle, aberrant remodeling of the vessel wall could be a culprit. 38 On a practical level, any gene studied should be selected based on some reasonable and plausible hypothesis, and because common genetics variants are expected to have modest effects, studies need to be adequately powered. 16, 39 The studies in this issue fulfil the plausibility criterion but the authors indicate some concern about sample size. (Self-evidently, genotyping of the highest quality is required to avoid unrecognized confounders.)
Perlecan (heparan sulfate proteoglycan, HSPG2) and versican (chondroitin sulfate proteoglycan, CSPG2) form part of the ECM. [40] [41] [42] [43] [44] They are both high-molecular-weight-glycosylated proteins, so-called proteoglycans. The perlecan gene is required for embryonic development and survival. Perlecan has different effects on different cell types. It interacts stimulatory with vascular endothelial cells (EC) to be pro-angiogenic, but with vascular smooth muscle cells (SMC), its action essentially is inhibitory, decreasing adhesion, migration, and proliferation. ApoE induces expression of perlecan in SMC. In addition, perlecan is considered antithrombotic. Oddly enough, transgenic mice lacking heparin sulfate sulfotransferase have been reported not to have increased risk of thrombosis. Versican has a role in the differentiation of mesenchyme into cartilage and is implicated in local tumor invasiveness and in systemic metastasis. It is one of the principal genes that is upregulated after vascular injury and is a prominent component in stented and nonstented restenotic lesions. Versican is found in advanced atherosclerotic lesions. It influences the assembly of the ECM and has a central role in elastic fiber fibrillogenesis (see above). Thus, perlecan and versican appear to be good candidates. The Utrecht group has previously reported that variation in or near the versican gene on chromosome 5q plays a role in the susceptibility to IAs. 45 Their results are consistent with Japanese findings of a link to 5q22-31. However, the Dutch study had a very small number of affected sib pairs. The SNPs lie in a region of the versican gene that includes the 2 largest exons (6 and 7) in which alternative RNA splicing occurs. It is, therefore, both interesting and intriguing that Baast et al find no relationship between HSPG2 and CSPG2 and AAA. 1 Their conclusion is that genetic variations between these proteoglycans differ in their contribution to the pathogenesis of IA and AAA. This seems reasonable given the substantially different demographics and risk factors for the 2 disorders. Results from other teams are needed.
The other study has investigated chromosome 19. 2 Ogata and Shibamura, using affected relative pair (ARP) linkage, reported the presence of susceptibility loci for familial AAA on chromosome 19q13 and, more weakly chromosome 4q31, but their modeling required a number of assumptions. 46, 47 They did not think chromosome 5 to be relevant. The region on chromosome 19 contains many plausible candidates. The study reported here found that none of the 615 tag SNPs they tested on chromosome 19q13 associate with AAA. 2 The authors discuss the limitations of their approach both in terms of theoretical considerations (such as rare variants or copy number variations of SNPs) and a number of technical considerations (such as the study may have been underpowered and not be able to control for confounding). They conclude that an explanation could simply be that familial AAA may be different from sporadic AAA. As noted elsewhere, studies like these require large number of subjects, so the results of the recently initiated collaborative AAA study are eagerly awaited. 48 Prevention is better than cure. Understanding the molecular pathogenesis of a disorder represents a milestone in the development of effective treatments and/or predictive tests, as illustrated by the development of statins. Thus, it can be hoped that better genetic knowledge will help AAA and IA. Given that risk factors such as smoking, hypertension, and alcohol can only be removed through the action of the individual, a better understanding of the genetics of risk may help target behavioral change. A therapeutic application is easier to see in AAA where the damaged vessel is more readily accessible than in IA. One option could be local injection of stem cells in or near an AAA to rebuild and strengthen the vessel wall. 49 Simply checking whether afflicted at genetic loci without any remedial action possible may well be music to the ears of insurance agents and actuaries but goes against established rules for screening. Nevertheless, there are 2 preventive steps that can be taken today: stop smoking and lower blood pressure.
The editor of Angiology is to be congratulated on finding space for negative results because it is well known that such results are hard to publish. 50 One hopes that these articles might become the dogs that did not bark in the night, to misquote Sherlock Holmes. It now behooves other groups to submit their reports on these genetic regions. Although unlikely, as Baas and coworkers note, their methodology may have missed weak signals. The genetic database for both studies is a group of Dutch people who are defined by having all their grandparents of Dutch origin. A replication or refutation of their findings based on the various databases around the world, including those in Japan, Korea, the state of Utah, and Iceland, is called for.
